Cybin (CYBN) said late Friday it closed a registered direct offering that raised about $175 million in gross proceeds.
The financing included roughly 22.3 million common shares and 4.6 million pre-funded warrants, each priced at $6.51.
Cybin said it plans to use the proceeds to repay unsecured convertible debentures held by High Trail Special Situations and to advance its clinical programs, as well as for general corporate purposes.
Shares of Cybin rose 1.6% in after-hours trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments